Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

NetworkNewsWire Editorial Coverage: As the American population gets older, chronic and rare diseases are becoming a significant healthcare issue, particularly for older adults.ย The aging populationโ€™s increasing life expectancy also leads to more complex healthcare needs, especially for conditions that are both chronic and difficult to diagnose.ย Many of these rare conditions lack FDA-approved treatments, and their symptoms in seniors areย frequently mistakenย for normal signs of aging, causing diagnostic delays that can last for years.ย There areย more than 30 million Americansย who have a rare disease, so there is a growing need for accurate diagnoses and effective treatments. The Trump administrationโ€™s โ€œMake America Healthy Againโ€ initiatives have highlighted this problem and focused on improving access to treatments and speeding up medical innovation.ย Soligenix Inc.ย (NASDAQ: SNGX) (Profile) is working to advance this mission with its HyBryte(โ€œTMโ€) platform, a new therapy for cutaneous T-cell lymphoma (โ€œCTCLโ€), a rare form of skin cancer that largely impacts older adults.ย The company has successfully established U.S.-based manufacturing for HyBryteโ€™s active ingredient, demonstrating the kind of domestic innovation that can significantly help this underserved patient group.ย Soligenix is one of several notable companies dedicated to making an impact in the pharmaceutical field, alongsideย Amgen Inc.ย (NASDAQ: AMGN),ย Amicus Therapeutics Inc.ย (NASDAQ: FOLD),ย Tonix Pharmaceuticals Holding Corp.ย (NASDAQ: TNXP) andโ€ฆ

Read More>>

About NetworkNewsWire

NetworkNewsWireย (โ€œNNWโ€) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 70+ brands withinย theย Dynamic Brand Portfolioย @ย IBNย that delivers:ย (1) access to a vast network of wire solutions viaย InvestorWireย to efficiently and effectively reach a myriad of target markets, demographics and diverse industries;ย (2) article andย editorial syndication to 5,000+ outlets;ย (3) enhancedย press release enhancementย to ensure maximum impact;ย (4)ย social media distributionย via IBN to millions of social media followers;ย and (5) a full array of tailoredย corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in todayโ€™s market, NNW brings its clients unparalleled recognition and brand awareness.

NNW is where breaking news, insightful content and actionable information converge.

For more information, please visitย www.NetworkNewsWire.com

Please view full terms of use and disclaimers on the NNW website applicable to all content provided by NNW, wherever published or re-published:ย http://www.nnw.fm/Disclaimer

NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is powered byย IBN

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuerโ€™s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuerโ€™s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains โ€œforward-looking statementsโ€ within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. โ€œForward-looking statementsโ€ describe future expectations, plans, results, or strategies and are generally preceded by words such as โ€œmayโ€, โ€œfutureโ€, โ€œplanโ€ or โ€œplannedโ€, โ€œwillโ€ or โ€œshouldโ€, โ€œexpected,โ€ โ€œanticipatesโ€, โ€œdraftโ€, โ€œeventuallyโ€ or โ€œprojectedโ€. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companyโ€™s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article